Bacterial Pneumonia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: Moxifloxacin; Other: Placebo to match solithromycinSponsor: Cempra PharmaceuticalsCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2012 Category: Research Source Type: clinical trials
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: PneumoniaIntervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)Sponsor: BayerRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2012 Category: Research Source Type: clinical trials
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: PneumoniaIntervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)Sponsor: BayerRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2012 Category: Research Source Type: clinical trials
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: PneumoniaIntervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)Sponsor: BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2012 Category: Research Source Type: clinical trials
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: PneumoniaIntervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)Sponsor: BayerRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2012 Category: Research Source Type: clinical trials
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: PneumoniaIntervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)Sponsor: BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2012 Category: Research Source Type: clinical trials
